View price in:  
Mysimba 112 Tabs (Naltrexone HCl / Bupropion HCl)
click to see larger image

Mysimba 112 Tabs (Naltrexone HCl / Bupropion HCl)

The latest European weight-loss drug
Contains Naltrexone and Bupropion
Non-Stimulant
Our Price:
USD219.99
Free Delivery
EU Licensed Pharmacy
Quantity:

Mysimba 112 Tabs (Naltrexone HCl / Bupropion HCl)
click to see larger image

Mysimba 112 Tabs (Naltrexone HCl / Bupropion HCl)

Product Reviews

Write an online review and share your thoughts.

WHAT


The latest weight loss drug to be approved by the European Union, Mysimba is a combination therapy drug released by US pharmaceutical company Orexigen. Containing naltrexone and bupropion, two drugs with a long established safety record and history of use globally, Mysimba is a non-stimulant fat burner making it a safer choice for patients, especially those with a history of obesity. It should be taken as part of a calorie controlled diet and with an exercise program.

WHY


Fat burning drugs are quite thin on the ground with the most obvious candidate, Xenical, being associated with a host of side effects. On the other hand, potent fat burners such as Clenbuterol carry with them a greatly increased risk of stimulant related side effects so the introduction of Mysimba finally offers patients a lower risk option that has been proven to work in studies.

WHO


Mysimba is recommended only for adults aged 18 years or older with a BMI of at least 30, the statistical definition of obesity.

WHEN


Mysimba is usually dosed once or twice daily as long as weight loss is desired by your clinician. Always refer to product literature.

PATIENT LEAFLET

The latest European weight-loss drug
Contains Naltrexone and Bupropion
Non-Stimulant